These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11689447)

  • 1. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.
    Rogatsky I; Zarember KA; Yamamoto KR
    EMBO J; 2001 Nov; 20(21):6071-83. PubMed ID: 11689447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
    Rogatsky I; Luecke HF; Leitman DC; Yamamoto KR
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16701-6. PubMed ID: 12481024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
    Sun Y; Tao YG; Kagan BL; He Y; Simons SS
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
    Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
    Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.
    Reily MM; Pantoja C; Hu X; Chinenov Y; Rogatsky I
    EMBO J; 2006 Jan; 25(1):108-17. PubMed ID: 16362036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
    Cha HJ; Park MT; Chung HY; Kim ND; Sato H; Seiki M; Kim KW
    Oncogene; 1998 Feb; 16(6):771-8. PubMed ID: 9488041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.
    Hong H; Kohli K; Garabedian MJ; Stallcup MR
    Mol Cell Biol; 1997 May; 17(5):2735-44. PubMed ID: 9111344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin.
    Tuckermann JP; Reichardt HM; Arribas R; Richter KH; Schütz G; Angel P
    J Cell Biol; 1999 Dec; 147(7):1365-70. PubMed ID: 10613894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.
    Dobrovolna J; Chinenov Y; Kennedy MA; Liu B; Rogatsky I
    Mol Cell Biol; 2012 Feb; 32(4):730-9. PubMed ID: 22158970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids.
    Subramaniam N; Treuter E; Okret S
    J Biol Chem; 1999 Jun; 274(25):18121-7. PubMed ID: 10364267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.
    Rollins DA; Kharlyngdoh JB; Coppo M; Tharmalingam B; Mimouna S; Guo Z; Sacta MA; Pufall MA; Fisher RP; Hu X; Chinenov Y; Rogatsky I
    Nat Commun; 2017 Nov; 8(1):1739. PubMed ID: 29170386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.
    Ichijo T; Chrousos GP; Kino T
    Mol Cell Endocrinol; 2008 Feb; 283(1-2):19-31. PubMed ID: 18096310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells.
    Fryer CJ; Kinyamu HK; Rogatsky I; Garabedian MJ; Archer TK
    J Biol Chem; 2000 Jun; 275(23):17771-7. PubMed ID: 10748103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors.
    Walfish PG; Yoganathan T; Yang YF; Hong H; Butt TR; Stallcup MR
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3697-702. PubMed ID: 9108040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
    Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
    Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of two CBP (cAMP-response-element-binding protein-binding protein) interacting sites in GRIP1 (glucocorticoid-receptor-interacting protein), and their importance for the function of GRIP1.
    Huang SM; Cheng YS
    Biochem J; 2004 Aug; 382(Pt 1):111-9. PubMed ID: 15137909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.
    Saatcioglu F; Lopez G; West BL; Zandi E; Feng W; Lu H; Esmaili A; Apriletti JW; Kushner PJ; Baxter JD; Karin M
    Mol Cell Biol; 1997 Aug; 17(8):4687-95. PubMed ID: 9234725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.